Skip to main content
SpringerLink
Log in

Bipolar Disorder

  • Chapter
The Practitioner’s Guide to Psychoactive Drugs

  • 143 Accesses

Abstract

Bipolar disorder is one of the most common and treatable of the mood disorders, affecting over 1% of adults in industrialized nations over the course of a lifetime.1 The essential feature of bipolar disorder is the presence of one or more manic episodes; usually, there is also a history of major depressive episodes. Bipolar II disorder is characterized by the occurrence of one or more major depressive episodes and at least one hypomanic episode.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Kessler R. C., McGonagle K. A., Zhao S., et al: Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Arch Gen Psychiatry 51: 8–19, 1994.

    Article  PubMed  CAS  Google Scholar 

  2. Muller-Oerlinghausen B., Ahrens B., Grof E., et al: The effect of long-term lithium treatment on the mortality of patients with manic-depressive and schizoaffective illness. Acta Psychiatr Scand 86: 218–222, 1992.

    Article  PubMed  CAS  Google Scholar 

  3. Weissman M. M., Bland R. C., Canino G. J., et al: Cross-national epidemiology of major depression and bipolar disorder. JAMA 276: 293–299, 1996.

    Article  PubMed  CAS  Google Scholar 

  4. Leibenluft E.: Women with bipolar illness: Clinical and research issues. Am J Psychiatry 153: 163–173, 1996.

    PubMed  CAS  Google Scholar 

  5. Krasa N. R.: Sex differences in age at first affective episode. Am J Psychiatry 152: 960, 1995.

    Google Scholar 

  6. McMahon F. J., Stine O. C., Chase G. A., Meyers D. A., Simpson S. G., DePaulo J. R., Jr.: Influence of clinical subtype, sex, and lineality on age at onset of major affective disorder in a family sample. Am J Psychiatry 151: 210–215, 1994.

    Google Scholar 

  7. Goodwin E K., Jamison K. R.: Manic-Depressive Illness. New York, Oxford University Press, 1990.

    Google Scholar 

  8. American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, Washington, D.C., American Psychiatric Association, 1994.

    Google Scholar 

  9. Calabrese J. R., Woyshville M. J., Kimmel S. E., Rapport D. J.: Mixed states and bipolar rapid cycling and their treatment with divalproex sodium. Psychiatr Ann 23: 70–78, 1993.

    Google Scholar 

  10. Dunner D. L., Fieve R. R.: Clinical factors in lithium carbonate prophylaxis failure. Arch Gen Psychiatry 30: 229–233, 1974.

    Article  PubMed  CAS  Google Scholar 

  11. Keller M. B., Lavori P. W., Coryell W., et al: Differential outcome of pure manic, mixed/cycling, and pure depressive episodes in patients with bipolar illness. JAMA 255: 3138–3142, 1986.

    Article  PubMed  CAS  Google Scholar 

  12. Prien R. F., Gelenberg A. J.: Alternatives to lithium for preventive treatment of bipolar disorder. Am J Psychiatry 146: 840–848, 1989.

    PubMed  CAS  Google Scholar 

  13. Cohen L. S., Sichel D. A., Robertson L. M., Heckscher E., Rosenbaum J. F.: Postpartum prophylaxis for women with bipolar disorder. Am J Psychiatry 152: 1641–1645, 1995.

    PubMed  CAS  Google Scholar 

  14. Kendell R. E., Chalmers J. C., Platz C.: Epidemiology of puerperal psychoses. Br J Psychiatry 150: 662–673, 1987.

    Article  PubMed  CAS  Google Scholar 

  15. Winokur G., Clayton P. J., Reich T.: Manic Depressive Disease. St. Louis, C.V. Mosby, 1969.

    Google Scholar 

  16. Post R. M.: Transduction of psychosocial stress into the neurobiology of recurrent affective disorder. Am J Psychiatry 149: 999–1010, 1992.

    PubMed  CAS  Google Scholar 

  17. Gelenberg A. J., Kane J. M., Keller M. B., et al: Comparison of standard and low serum levels of lithium for maintenance treatment of bipolar disorder. N Engl J Med 321: 1489–1493, 1989.

    Article  PubMed  CAS  Google Scholar 

  18. Altshuler L. L.: Bipolar disorder: Are repeated episodes associated with neuroanatomic and cognitive changes? Biol Psychiatry 33: 563–565.

    Article  PubMed  CAS  Google Scholar 

  19. Friedman M., Culver C., Ferrell R.: On the safety of long-term treatment with lithium. Am J Psychiatry 134: 1123–1126, 1977.

    PubMed  CAS  Google Scholar 

  20. Savard R. J., Rey A. C., Post R. M.: Halstead-Reitan category test in bipolar and unipolar affective disorders: Relationship to age and phase of illness. J Nerv Ment Dis 168: 297–304, 1980.

    Article  PubMed  CAS  Google Scholar 

  21. Hauser P., Altshuler L. L., Berrettini W., Dauphinais I. D., Gelernter J., Post R. M.: Temporal lobe measurement in primary affective disorder by magnetic resonance imaging. J Neuropsychol 1: 128–134, 1989.

    CAS  Google Scholar 

  22. Altshuler L. L., Conrad A., Hauser P., Li X., Guze B., Post R. M.: Temporal lobe volume in bipolar disorder: A preliminary report. Arch Gen Psychiatry 48: 482–483, 1991.

    Article  PubMed  CAS  Google Scholar 

  23. Coffman, J. A., Bornstein R. A., Olson S. C., Schwarzkopf S. B., Nasrallah H.: Cognitive impairment and cerebral structure by MRI in bipolar disorder. Biol. Psychiatry.

    Google Scholar 

  24. Swayze V. W., II, Andreasen N. C., Alliger R. J., Yuh W. T. C., Ehrhardt J. C.: Subcortical and temporal structures in affective disorder and schizophrenia: A magnetic resonance imaging study. Biol Psychiatry 31: 221–240, 1992.

    Article  PubMed  Google Scholar 

  25. Dolan R. J., Calloway P., Mann A. H.: Cerebral ventricular size in depressed subjects. Psychol Med 15: 873, 1985.

    Google Scholar 

  26. Andreasen N. C., Swayze V. W., II, Flaum M., Alligen R., Cohen G.: Ventricular abnormalities in affective disorder: Clinical and demographic correlates. Am J Psychiatry 147: 893–900, 1990.

    Google Scholar 

  27. Mclnnis M. G., McMahon F. J., Chase G. A., Simpson S. G., Ross C. A., DePaulo J. R. J.: Anticipation in bipolar affective disorder. Am J Hum Genet 53: 385–390, 1993.

    Google Scholar 

  28. Clift E.: Data Consortium to search for genes causing manic-depressive illness. Psychiatric Times 1993;10: l-3.

    Google Scholar 

  29. Weissman M. M., Leaf P. J., Livingston B. M., et al: The epidemiology of dysthymia in the community: Rates, risks, comorbidity and treatment, in 140th Annual Meeting of the American Psychiatric Association. Chicago, American Psychiatric Association, 1987.

    Google Scholar 

  30. Anonymous: Medical Practice Project: A State-of the-Science Report for the Office of the Assistant Secretary for the U.S. Department of Health, Education and Welfare, 1979 (Abstract).

    Google Scholar 

  31. Mukherjee S., Sackeim H. A., Schnur D. B.: Electroconvulsive therapy of acute manic episodes: A review of 50 years’ experience. Am J Psychiatry 151: 169–176, 1994.

    PubMed  CAS  Google Scholar 

  32. Small J. G., Klapper M. H., Kellams J. J., et al: Electroconvulsive treatment compared with lithium in the management of manic states. Arch Gen Psychiatry 45: 727–732, 1988.

    Article  PubMed  CAS  Google Scholar 

  33. Coffey C. E., Winer R. D.: Electroconvulsive therapy: An update. Hosp Community Psychiatry 41: 515–521, 1990.

    PubMed  CAS  Google Scholar 

  34. Consensus Development Conference: Electroconvulsive therapy. JAMA 254: 2103–2108, 1985.

    Article  Google Scholar 

  35. Segman R. H., Shapira B., Gorfine M., Lerer B.: Onset and time course of antidepressant action: Psychopharmacological implications of a controlled trial of electroconvulsive therapy. Psychopharmacology 119: 440–448, 1995.

    Article  PubMed  CAS  Google Scholar 

  36. Fieve R. R.: The lithium clinic: A new model for the delivery of psychiatric services. Am J Psychiatry 132: 1018–1022, 1975.

    PubMed  CAS  Google Scholar 

  37. Shakir S. A., Volkmar F. R., Bacon S., Pfefferbaum A.: Group psychotherapy as an adjunct to lithium maintenance. Am J Psychiatry 136: 455–456, 1979.

    PubMed  CAS  Google Scholar 

  38. Kripke D. F., Robinson D.: Ten years with a lithium group. McLean Hosp 10: 1–11, 1985.

    Google Scholar 

  39. Volkmar F. R., Bacon S., Shakir S. A., et al: Group therapy in the management of manic-depressive illness. Am J Psychother 35: 226–234, 1981.

    PubMed  CAS  Google Scholar 

  40. Davenport Y. B., Ebert M. H., Adland M. L., Goodwin F. K.: Couples group therapy as an adjunct to lithium maintenance of the manic patient. Am J Orthopsychiatry 47: 495–502, 1977.

    Article  PubMed  CAS  Google Scholar 

  41. Glick I. D., Clarkin J. F., Spencer J. H., et al: A controlled evaluation of inpatient family intervention: Preliminary results of the six-month follow-up. Arch Gen Psychiatry 42: 882–886, 1985.

    Article  PubMed  CAS  Google Scholar 

  42. Miklowitz D. J., Goldstein M. J.: Behavioral family treatment for patients with bipolar affective disorder. Behav Modif 4: 457–489, 1990.

    Article  Google Scholar 

  43. Miller I. W., Keitner G. I., Epstein N. B., Bishop D. S., Ryan C. E.: Families of bipolar patients: Dysfunction, course of illness, and pilot treatment study. 1991 (Abstract).

    Google Scholar 

  44. Scott J.: Psychotherapy for bipolar disorder. Br J Psychiatry 167: 581–588, 1995.

    Article  PubMed  CAS  Google Scholar 

  45. Cochran S. D.: Preventing medical noncompliance in the outpatient treatment of bipolar affective disorders. J Consult Clin Psychol 52: 873–878, 1984.

    Article  PubMed  CAS  Google Scholar 

  46. Price L. H., Heninger G. R.: Lithium in the treatment of mood disorders. N Engl J Med 331: 591–598, 1994.

    Article  PubMed  CAS  Google Scholar 

  47. Manji H. K., Potter W. Z., Lenox R. H.: Signal transduction pathways: Molecular targets for lithium’s actions. Arch Gen Psychiatry 52: 531–543, 1995.

    Article  PubMed  CAS  Google Scholar 

  48. Pollack S. J., Atack J. R., Knowles M. R., et al: Mechanism of inositol monophosphatase, the putative target of lithium therapy. Proc Natl Acad Sci U.S.A. 91: 5766–5770, 1994.

    Article  PubMed  CAS  Google Scholar 

  49. Berridge M. J., Downes C. P., Hanley M. R.: Neural and developmental actions of lithium: A unifying hypothesis. Cell 59: 411–419, 1989.

    Article  PubMed  CAS  Google Scholar 

  50. Baraban J. M.: Toward a crystal-clear view of lithium’s site of action. Proc Natl Acad Sci U.S.A. 91: 5738–5739, 1994.

    Article  PubMed  CAS  Google Scholar 

  51. Manji H. K., Chen G., Shimon H., Hsiao J. K., Potter W. Z., Belmaker R. H.: Guanine nucleotide-binding proteins in bipolar affective disorder: Effects of long-term lithium treatment. Arch Gen Psychiatry 52: 135–144, 1995.

    Article  PubMed  CAS  Google Scholar 

  52. Keller M. B., Lavori P. W., Kane J. M., et al: Subsyndromal symptoms in bipolar disorder: A comparison of standard and low serum levels of lithium. Arch Gen Psychiatry 49: 371–376, 1992.

    Article  PubMed  CAS  Google Scholar 

  53. Fieve R. R.: Overview of therapeutic and prophylactic trials with lithium in psychiatric patients, in Gershon S., Shopsin B. (eds): Lithium. Its Role in Psychiatric Research and Treatment. New York, Plenum Press, 1973, p. 336.

    Google Scholar 

  54. Van Putten T.: Why do patients with manic-depressive illness stop their lithium? Compr Psychiatry 16: 179–183, 1975.

    Article  PubMed  Google Scholar 

  55. Cooper T. B.: Pharmacokinetics of lithium, in Meltzer H. Y. (ed): Psychopharmacology: The Third Generation of Progress. New York, Raven Press; 1987, pp. 1365-1376.

    Google Scholar 

  56. Schou M., Anderson A., Eskajaer-Jensen S., et al: Occurrence of goiter during lithium treatment. Br J Med 3: 710–713, 1968.

    Article  CAS  Google Scholar 

  57. Emerson C. H., Dyson W. L., Utiger R. D.: Serum thyrotropin and thyroxin concentration in patients receiving lithium carbonate. J Clin Endocrinol Metab 36: 338–346, 1973.

    Article  PubMed  CAS  Google Scholar 

  58. Jefferson J. W.: Lithium carbonate-induced hypothyroidism—its many faces. JAMA 242: 271–272, 1979.

    Article  PubMed  CAS  Google Scholar 

  59. VanderVelde C. D., Gordon M. W.: Manic-depressive illness, diabetes mellitus and lithium carbonate treatment. Arch Gen Psychiatry 21: 478–485, 1969.

    Article  PubMed  Google Scholar 

  60. Mellerup E. T., Plenge P., Rafaelson O. J.: Renal and other controversial adverse effects of lithium, in Meltzer H. Y. (ed): Psychopharmacology: The Third Generation of Progress. New York, Raven Press; 1987, pp. 1443-1448.

    Google Scholar 

  61. Gelenberg A. J.: Lithium-induced polyuria: Approaches to management. Biol Ther Psychiatry Newslett 6: 17–19, 1983.

    Google Scholar 

  62. Gelenberg A. J., Wojcik J. D., Falk W. E., et al: Effects of lithium on the kidney. Acta Psychiatr Scand 75: 29–34, 1987.

    Article  CAS  Google Scholar 

  63. Gitlin M. J.: Lithium-induced renal insufficiency. J Clin Psychopharmacol 13: 276–279, 1993.

    PubMed  CAS  Google Scholar 

  64. Gelenberg A. J.: Lithium and the nephrotic syndrome. Biol Ther Psychiatry 12: 24, 1989.

    Google Scholar 

  65. Shopsin B., Gershon S.: Pharmacology-toxicology of the lithium ion, in Gershon S., Shopsin B. (eds): Lithium: Its Role in Psychiatric Research and Treatment. New York, Plenum Press; 1973, pp. 107-146.

    Google Scholar 

  66. Schou M.: Electrocardiographic changes during treatment with lithium and with drugs of the imipramine type. Acta Psychiatr Scand 169: 258–259, 1963.

    Google Scholar 

  67. Roose S. P., Nurnberger J. L., Dunner D. L., et al: Cardiac sinus node dysfunction during lithium treatment. Am J Psychiatry 136: 804–806, 1979.

    PubMed  CAS  Google Scholar 

  68. Jaffe C. M.: First-degree atrioventricular block during lithium carbonate treatment. Am J Psychiatry 134: 88–89, 1977.

    PubMed  CAS  Google Scholar 

  69. Worthley L. J. C.: Lithium toxicity and refractory cardiac arrhythmia treated with intravenous magnesium. Anesth Intens Care 2: 357–360, 1974.

    CAS  Google Scholar 

  70. Gelenberg A. J., Jefferson J. W.: Lithium tremor. J Clin Psychiatry 56: 283–287, 1995.

    PubMed  CAS  Google Scholar 

  71. Jefferson J. W., Greist J. H.: Adverse reactions—neurological tremor, in Jefferson J. W., Greist J. H. (eds): Primer of Lithium Therapy. Baltimore, Williams & Wilkins, 1977, pp. 139-150.

    Google Scholar 

  72. Ghandirian A. M., Lehman H. E.: Neurological side effects of lithium: Organic brain syndrome, seizures, extrapyramidal side effects, and EEG changes. Compr Psychiatry 21: 327–335, 1980.

    Article  Google Scholar 

  73. Levine S. H., Puchalski C.: Pseudotumor cerebri associated with lithium therapy in two patients. J Clin Psychiatry 51: 251–253, 1990.

    PubMed  CAS  Google Scholar 

  74. Alvarez-Cermeno J. C., Fernandez J. M., O’Neill A., Moral L., Saiz-Ruiz J.: Lithium-induced headache. Headache 29: 246–247, 1989.

    Article  PubMed  CAS  Google Scholar 

  75. Saul R. F., Hamburger H. A., Selhorst J. B.: Pseudotumor cerebri secondary to lithium carbonate. JAMA 253: 2869–2870, 1985.

    Article  PubMed  CAS  Google Scholar 

  76. Pesando P., Nuzzi G., Maraini G.: Bilateral papilloedema in long term therapy with lithium carbonate. Pharmakopsychiatr Neuro-Psychopharmakol 13: 235–239, 1980.

    CAS  Google Scholar 

  77. Lobo A., Pilek E., Stokes P. E.: Papilledema following therapeutic dosages of lithium carbonate. J Nerv Ment Dis 166: 526–529, 1978.

    Article  PubMed  CAS  Google Scholar 

  78. Gelenberg A. J.: Polypharmacy in psychiatry: Balancing caution with daring. CNS Drugs 4: 410–411, 1995.

    Article  Google Scholar 

  79. Schou M.: Long-lasting neurological sequelae after lithium intoxication. Acta Psychiatr Scand 70: 594–602, 1984.

    Article  CAS  Google Scholar 

  80. Cohen L. S., Friedman J. M., Jefferson J. W., Johnson E. M., Weiner M. L.: A reevaluation of risk of in utero exposure to lithium. JAMA 271: 146–150, 1994.

    Article  PubMed  CAS  Google Scholar 

  81. Thase M. E., Rush A. J.: Treatment-resistant depression, in Bloom F. E., Kupfer D. J. (eds): Psychopharmacology: The Fourth Generation of Progress. New York, Raven Press; 1995, pp. 1081–1097.

    Google Scholar 

  82. Donaldson S. R., Gelenberg A. J., Baldessarini R. J.: The pharmacologic treatment of schizophrenia: A progress report. Schizophrenia Bull 9: 504–527, 1983.

    Article  CAS  Google Scholar 

  83. Gjessing L. R.: Lithium citrate loading of a patient with periodic catatonia. Acta Psychiatr Scand 43: 372–375, 1967.

    Article  CAS  Google Scholar 

  84. Kline N. S., Wren J. C., Cooper T. B., et al: Evaluation of lithium therapy in chronic and periodic alcoholism. Am J Med Sci 268: 15–22, 1974.

    Article  PubMed  CAS  Google Scholar 

  85. Rifkin A., Quitkin F., Carrillo R., et al: Lithium carbonate in emotionally unstable character disorder. Arch Gen Psychiatry 27: 519–522, 1972.

    Article  PubMed  CAS  Google Scholar 

  86. Gottfries C. G.: The effect of lithium salts on various kinds of psychiatric disorders. Acta Psychiatr Scand 203: 157–167, 1968.

    Article  CAS  Google Scholar 

  87. American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, DSM-III-R. Washington, D.C., American Psychiatric Association, 1987.

    Google Scholar 

  88. Bowden C. L., Brugger A. M., Swann A. C., et al: Efficacy of divalproex vs. lithium and placebo in the treatment of mania. JAMA 271: 918–924, 1994.

    Article  PubMed  CAS  Google Scholar 

  89. Prien R. F., Caffey E. M., Klett C. J.: A comparison of lithium carbonate and chlorpromazine in the treatment of acute mania. Arch Gen Psychiatry 26: 146–153, 1972.

    Article  PubMed  CAS  Google Scholar 

  90. Shopsin B., Gershon S., Thompson H., Collins P.: Psychoactive drugs in mania: A controlled comparison of lithium carbonate, chlorpromazine, and haloperidol. Arch Gen Psychiatry 32: 34–42, 1975.

    Article  PubMed  CAS  Google Scholar 

  91. Post R. M., Jimerson D. C., Bunney W. E., Jr., Goodwin F. K.: Dopamine and mania: Behavioral and biochemical effects of the dopamine receptor blocker pimozide. Psychopharmacology (Berlin) 67: 297–305, 1980.

    Article  CAS  Google Scholar 

  92. Cookson J. C., Silverstone T., Wells B.: A double-blind controlled study of pimozide versus chlorpromazine in mania. Psychopharmacol Bull 16: 38–41, 1980.

    PubMed  CAS  Google Scholar 

  93. Kessel J. B., Verghese C., Simpson G. M.: Neurotoxicity related to lithium and neuroleptic combinations? A retrospective review. J Psychiatry Neurosci 17: 28–30, 1992.

    PubMed  CAS  Google Scholar 

  94. Spring G., Frankel M.: New data on lithium and haloperidol incompatibility. Am J Psychiatry 138: 818–821, 1981.

    PubMed  CAS  Google Scholar 

  95. Zarate C. A., Tohen M., Baldessarini R. J.: Clozapine in severe mood disorders. J Clin Psychiatry 56: 411–417, 1995.

    PubMed  Google Scholar 

  96. Suppes T., McElroy S. L., Gilbert J., Dessain E. C., Cole J. O.: Clozapine in the treatment of dysphoric mania. Biol Psychiatry 32: 270–280, 1992.

    Article  PubMed  CAS  Google Scholar 

  97. Kimmel S. E., Calabrese J. R., Woyshville M. J., Meltzer H. Y.: Clozapine in treatment-refractory mood disorders. J Clin Psychiatry 55: 91–93, 1994.

    PubMed  Google Scholar 

  98. Calabrese J. R., Kimmel S. E., Woyshville M. J., et al: Clozapine for treatment-refractory mania. Am J Psychiatry 153: 759–764, 1996.

    PubMed  CAS  Google Scholar 

  99. Calabrese J. R., Meltzer H. Y., Markovitz P. J.: Clozapine prophylaxis in rapid cycling bipolar disorder. J Clin Psychopharmacol 11: 396–397, 1991.

    Article  PubMed  CAS  Google Scholar 

  100. Goodnick P. J.: Risperidone treatment of refractory acute mania. J Clin Psychiatry 56: 431–432, 1995.

    PubMed  CAS  Google Scholar 

  101. Tohen M., Zarate C. A., Jr., Centorrino F., Hegarty J., Froeschl M., Zarate S. B.: Risperidone in the treatment of mania. J Clin Psychiatry 57: 249–253, 1996.

    PubMed  CAS  Google Scholar 

  102. Dwight M. M., Keck P. E., Jr., Stanton S. P., Strakowski S. M., McElroy S. L.: Antidepressant activity and mania associated with risperidone treatment of schizoaffective disorder. Lancet 344: 554–555, 1994.

    Article  PubMed  CAS  Google Scholar 

  103. Koek R. J., Kessler C. C.: Probable induction of mania by risperidone. J Clin Psychiatry 57: 174–175, 1996.

    PubMed  CAS  Google Scholar 

  104. Tomlinson W. C.: Risperidone and mania. Am J Psychiatry 153: 132–133, 1996.

    PubMed  CAS  Google Scholar 

  105. Naylor G., Scott C.: Depot injections for affective disorders. Br J Psychiatry 136: 105, 1980.

    Google Scholar 

  106. Lowe M., Batchelor D.: Depot neuroleptics and manic depressive psychosis. Int J Clin Psychopharmacol 1: 53–62, 1986.

    Google Scholar 

  107. White E., Cheung P., Silverstone T.: Depot antipsychotics in bipolar affective disorder. Int Clin Psychopharmacol 8: 119–122, 1993.

    Article  PubMed  CAS  Google Scholar 

  108. Esparon J., Kalloor J., Naylor G. J., et al: Comparison of the prophylactic action of flupenthixol with placebo in lithium treated manic depressive patients. Br J Psychiatry 148: 723–725, 1986.

    Article  PubMed  CAS  Google Scholar 

  109. Littlejohn R., Leslie F., Cookson J.: Depot antipsychotics in the prophylaxis of bipolar affective disorder. Br J Psychiatry 165: 827–829, 1994.

    Article  PubMed  CAS  Google Scholar 

  110. Ahlfors U. G., Baastrup P. C., Dencker S. J., et al: Flupenthixol decanoate in recurrent manic depressive illness. Acta Psychiatr Scand 64: 226–237, 1981.

    Article  PubMed  CAS  Google Scholar 

  111. Sachs G. S.: Adjuncts and alternatives to lithium therapy for bipolar affective disorder. J Clin Psychiatry 50: 31–39, 1989.

    PubMed  Google Scholar 

  112. Sernyak M. J., Woods S. W.: Chronic neuroleptic use in manic-depressive illness. [Review]. Psychopharmacol Bull 29: 375–381, 1993.

    PubMed  CAS  Google Scholar 

  113. Sernyak M. J., Griffin R. A., Johnson R. M., Pearsall H. R., Wexler B. E., Woods S. W.: Neuroleptic exposure following inpatient treatment of acute mania with lithium and neuroleptic. Am J Psychiatry 151: 133–135, 1994.

    PubMed  CAS  Google Scholar 

  114. Vestergaard P., Schou M.: Prospective studies on a lithium cohort. Acta Psychiatr Scand 78: 421–426, 1988.

    Article  CAS  Google Scholar 

  115. Goodwin F. K., Murphy D. L., Bunney W. E., Jr.: Lithium carbonate treatment in depression and mania: A longitudinal double-blind study. Arch Gen Psychiatry 21: 486–496, 1969.

    Article  PubMed  CAS  Google Scholar 

  116. Goodwin F. K., Murphy D. L., Dunner D. L., Bunney W. E., Jr.: Lithium response in unipolar versus bipolar depression. Am J Psychiatry 129: 44–47, 1972.

    PubMed  CAS  Google Scholar 

  117. Noyes R., Jr., Dempsey G. M., Blum A., Cavanaugh G. L.: Lithium treatment of depression. Compr Psychiatry 15: 187–193, 1974.

    Article  PubMed  Google Scholar 

  118. Baron M., Gershon E. S., Rudy V., Jonas W. Z., Buchsbaum M.: Lithium carbonate response in depression: Prediction by unipolar/bipolar illness, average-evoked response, catechol-O-methyl transferase, and family history. Arch Gen Psychiatry 342: 1107–1111, 1975.

    Article  Google Scholar 

  119. Mendels J.: Lithium in the treatment of depressive states, in Johnson F. N. (ed): Lithium Research and Therapy. New York, Academic Press; 1975, pp. 43-62.

    Google Scholar 

  120. Altshuler L. L., Post R. M., Leverich G. S., Mikalauskas K., Rosoff A., Ackerman L.: Antidepressant-induced mania and cycle acceleration: A controversy revisited. Am J Psychiatry 152: 1130–1138, 1995.

    PubMed  CAS  Google Scholar 

  121. Stoll A. L., Mayer P. V., Kolbrener M., et al: Antidepressant-associated mania: A controlled comparison with spontaneous mania. Am J Psychiatry 151: 1642–1645, 1994.

    PubMed  CAS  Google Scholar 

  122. Bauer M. S., Calabrese J., Dunner D. L., et al: Multisite data reanalysis of the validity of rapid cycling as a course modifier for bipolar disorder in DSM-IV. Am J Psychiatry 151: 506–515, 1994.

    PubMed  CAS  Google Scholar 

  123. Sachs G. S., Lafer B., Stoll A. L., et al: A double-blind trial of bupropion versus desipramine for bipolar depression. J Clin Psychiatry 55: 391–393, 1994.

    PubMed  CAS  Google Scholar 

  124. Himmelhoch J. M., Thase M. E., Mallinger A. G., Houck P.: Tranylcypromine versus imipramine in anergic bipolar depression. Am J Psychiatry 148: 910–916, 1991.

    PubMed  CAS  Google Scholar 

  125. Bowden C. L.: Role of newer medications for bipolar disorder. J Clin Psychopharmacol 16: 48S-55S, 1996.

    Google Scholar 

  126. Calabrese J. R., Fatemi S. H., Woyshville M. J.: Antidepressant effects of lamotrigine in rapid cycling bipolar disorder. Am J Psychiatry 153: 1236, 1996.

    PubMed  CAS  Google Scholar 

  127. Gregersen H., Nielsen J. S., Peterslund N. A.: Acute porphyria and multiple organ failure during treatment with lamotrigine. Ugeskr Laeg 158: 4091–4092, 1996.

    Google Scholar 

  128. Hennessy M. J., Wiles C. M.: Lamotrigine encephalopathy. Lancet 347: 974–975, 1996.

    Article  PubMed  CAS  Google Scholar 

  129. Campistol J., Geli M., Llistosella E., Molins J., Llobert M.: [Stevens-Johnson syndrome after lamotrigine treatment]. Rev Neurol 23: 1236–1238, 1995.

    PubMed  CAS  Google Scholar 

  130. Sterker M., Berrouschot J., Schneider D.: Fatal course of toxic epidermal necrolysis under treatment with lamotrigine. Int J Clin Pharmacol Ther 33: 595–597, 1995.

    PubMed  CAS  Google Scholar 

  131. Makin A. J., Fitt S., Williams R., Duncan J. S.: Fulminant hepatic failure induced by lamotrigine. Br Med J 311: 292, 1995.

    Google Scholar 

  132. Anderson G. D., Yau M. K., Gidal B. E., et al: Bidirectional interaction of valproate and lamotrigine in healthy subjects. Clin Pharmacol Ther 60: 145–156, 1996.

    Google Scholar 

  133. Giannini A. J., Houser W. L., Jr., Loiselle R. H., Giannini M. C., Price WA: Antimanic effects of verapamil. Am J Psychiatry 141: 1602–1603, 1984.

    PubMed  CAS  Google Scholar 

  134. Garza-Trevino E. S., Overall J. E., Hollister L. E.: Verapamil versus lithium in acute mania. Am J Psychiatry 149: 121–122, 1992.

    PubMed  CAS  Google Scholar 

  135. Dubovsky S. L., Franks R. D., Allen S., Murphy J.: Calcium antagonists in mania: A double-blind study of verapamil. Psychiatry Res 18: 309–320, 1986.

    Article  PubMed  CAS  Google Scholar 

  136. Popkin M. K.: Patients with multiple sclerosis presenting to psychiatric hospitals. J Clin Psychiatry 56: 307–308, 1995.

    Google Scholar 

  137. Brady K. T., Sonne S. C.: The relationship between substance abuse and bipolar disorder. J Clin Psychiatry 56: 19–24, 1995.

    PubMed  Google Scholar 

  138. Regier D. A., Farmer M. E., Rae D. S., et al: Comorbidity of mental disorders with alcohol and other drug abuse: Results from the Epidemiologic Catchment Area (ECA) study. JAMA 264: 2511–2518, 1990.

    Article  PubMed  CAS  Google Scholar 

  139. Brady K. T., Sonne S. C., Anton R., Ballenger J. C.: Valproate in the treatment of acute bipolar affective episodes complicated by substance abuse: A pilot study. J Clin Psychiatry 56: 118–121, 1995.

    PubMed  CAS  Google Scholar 

  140. Prien R. F., Potter W Z.: NIMH workshop report on treatment of bipolar disorder. Psychopharmacol Bull 26: 409–427, 1990.

    PubMed  CAS  Google Scholar 

  141. Bowden C. L.: Predictors of response to divalproex and lithium. J Clin Psychiatry 56: 25–30, 1995.

    PubMed  Google Scholar 

  142. Zetin M., Garber D., De Antonio M., et al: Prediction of lithium dose: A mathematical alternative to the test-dose method. J Clin Psychiatry 47: 175–178, 1986.

    PubMed  CAS  Google Scholar 

  143. Zetin M., Shokooh S., Daghighi-Asi A., et al: Prediction of lithium dose: A follow-up study. Lithium 1: 182–183, 1990.

    Google Scholar 

  144. Cummings M. A., Haviland M. G., Wareham J. G., et al: A prospective clinical evaluation of an equation to predict daily lithium dose. J Clin Psychiatry 54: 55–58, 1993.

    PubMed  CAS  Google Scholar 

  145. Terao T., Oga T., Nozaki S., et al: A further prospective evaluation of an equation to predict daily lithium dose. J Clin Psychiatry 56: 193–195, 1995.

    PubMed  CAS  Google Scholar 

  146. McElroy S. L., Keck P. E., Stanton S. P., Tugrul K. C., Bennett J. A., Strakowski S. M.: A randomized comparison of divalproex oral loading versus haloperidol in the initial treatment of acute psychotic mania. J Clin Psychiatry 57: 142–146, 1996.

    PubMed  CAS  Google Scholar 

  147. Frances A., Docherty J. P., Kahn D. A., Carpenter D.: The expert concensus guideline series: Treatment of bipolar disorder. J Clin Psychiatry, 57 (Suppl 12A): 1-88, 1996.

    Google Scholar 

  148. Stoll A. L., Locke C. A., Vuckovic A., Mayer P. V.: Lithium associated cognitive and functional deficits reduced by a switch to divalproex sodium: A case series. J Clin Psychiatry 57: 356–359, 1996.

    Article  PubMed  CAS  Google Scholar 

  149. Solomon D. A., Ryan C. E., Keitner G. I., et al: A pilot study of lithium carbonate plus divalproex sodium for the continuation and maintenance treatment of patients with bipolar I disorder. J Clin Psychiatry 58: 95–99, 1997.

    Article  PubMed  CAS  Google Scholar 

  150. Wehr T. S., Goodwin F. K.: Can antidepressants cause mania and worsen the course of affective illness? Am J Psychiatry 144: 1403–1411, 1987.

    PubMed  CAS  Google Scholar 

  151. Roy-Byrne P. P., Joffe R. T., Uhde T. W., Post R. M.: Approaches to the evaluation and treatment of rapid-cycling affective illness. Br J Psychiatry 145: 543–550, 1984.

    Article  PubMed  CAS  Google Scholar 

  152. Price W. A., DiMarzio L.: Premenstrual tension syndrome in rapid-cycling bipolar affective disorder. J Clin Psychiatry 47: 415–417, 1986.

    PubMed  CAS  Google Scholar 

  153. Stoll A. L., Sachs G. S., Cohen B. M., Lafer B., Christensen J. D., Renshaw P. F.: Choline in the treatment of rapid-cycling bipolar disorder: Clinical and neurochemical findings in lithium-treated patients. Biol Psychiatry 40: 382–388, 1996.

    Article  PubMed  CAS  Google Scholar 

  154. Jacobsen F. M.: Low-dose valproate: A new treatment for cyclothymia, mild rapid cycling disorders, and premenstrual syndrome. J Clin Psychiatry 54: 229–234, 1993.

    PubMed  CAS  Google Scholar 

  155. Privitera M. R., Lamberti J. S., Maharaj K.: Clozapine in a bipolar depressed patient. Am J Psychiatry 150: 986, 1993.

    Google Scholar 

  156. Goodnick P. J.: Nimodipine treatment of rapid cycling bipolar disorder. J Clin Psychiatry 56: 330, 1995.

    Google Scholar 

  157. Benjamin J., Zohar J.: Sleep deprivation in rapid-cycling bipolar affective disorder: Case report. Eur Neuropsychopharmacol 2: 463–465, 1992.

    Google Scholar 

  158. Kasper S., Wehr T. A.: The role of sleep and wakefulness in the genesis of depression and mania. Encephale 18: 45–50, 1992.

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Psychiatry, University of Arizona Health Sciences Center, Tucson, Arizona, 85724, USA

    Heather S. Hopkins & Alan J. Gelenberg M.D.

Authors
  1. Heather S. Hopkins
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Alan J. Gelenberg M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. University of Arizona College of Medicine, Tucson, Arizona, USA

    Alan J. Gelenberg M.D.

  2. The Better Homes Fund, Newton Centre, Massachusetts and Harvard Medical School, Boston, Massachusetts, USA

    Ellen L. Bassuk M.D.

Rights and permissions

Reprints and permissions

Copyright information

© 1998 Springer Science+Business Media New York

About this chapter

Cite this chapter

Hopkins, H.S., Gelenberg, A.J. (1998). Bipolar Disorder. In: Gelenberg, A.J., Bassuk, E.L. (eds) The Practitioner’s Guide to Psychoactive Drugs. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-5877-4_3

Download citation

  • DOI: https://doi.org/10.1007/978-1-4615-5877-4_3

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4613-7695-8

  • Online ISBN: 978-1-4615-5877-4

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation